Member Info for troutisout

Ricky about 337k buys in the sell column on LSE

Only works if the Broker understands the problem, II obviously don't.....Latest....

POOLBEG PHARMA LTD POOLBEG UNLISTED RESTRICTED
Description ISA-Ineligible Holding - Correction

Name of stock: Poolbeg Pharma
Date by which you need to transfer, or request withdrawal: 9th March 2022
Since issuing our original notice concerning the ISA-ineligibility of Poolbeg Pharma restricted shares, we have identified that the option to have shares withdrawn and re-registered into your own name is not available on this stock, because of the restricted nature of the security. Therefore, the notice should have read as follows;
Your Poolbeg Pharma restricted shares are not deemed to be ISA-eligible under HMRC rules. You therefore have until 9th March 2022 to request that we move them from your ISA account into your ii Trading account if you have one. In order to move the shares please select ?Cash & Transfers? from your account page, then ?Transfer in?, and ?Account to Account Transfer?. A new page will open where you will be able to instruct us to transfer the shares.
If you take no action before 9th March 2022, we will endeavour to remove the shares from your ISA. This may involve transferring the shares into your Trading account if you have one, or opening a Trading account on your behalf and transferring the shares into that account. Which of these options applies will be determined by us at the time in our capacity as the ISA Manager.
Withdrawals are not possible for Junior ISA Accounts so if you hold these shares in a Junior ISA they will remain on the account.
Please accept our apologies for any confusion caused.

I am acutely aware the SP has been in decline for months, I am pointing out that the recent drop and lack of investor appetite for buying is far more likely to do with the Ukraine situation than the Company. Look at some shares that will have similar investors, the Covid 'darlings', look at the ones based in Russia. Huge drops and that will have a knock on effect, less free money slopping around, margin calls and the realisation that when the tide goes out all the boats drop (some may be higher up the shore but they all drop).
The constant whining at this current time is pointless, if CF announced a new £50m contract tomorrow, half the investors here haven't got any more to invest, many investors elsewhere are nursing losses and so will have little to invest, any rise will get sold into by some of the 'holders' here.....
In short have some patience, the Macro situation has taken over.
I'd rather be down on my holding here, than down in my cellar, have a bit of perspective...

Yes it's almost like there is nothing else happening in the World which might be depressing the SP here and putting off new investors buying any shares.

Perhaps some of the naive investors can now stop whining about Director's buying shares.
In a fast developing Company there is very little chance to find a window when they aren't in the knowledge of inside information. There are rules in place and they are there to safeguard investors and stop Management and staff from profiting from being inside.

You can't do a large scale Phase 3 trial without an amount of Influenza in the population. At the moment there is very little Worldwide due to Covid and Covid measures.
Why don't you calm down....

Certainly is....

https://www.youtube.com/watch?v=ujYBnYlEVII

Click on the i button on the screen and then go to the full report.

CF only needs to update by RNS, when something has been signed, sold or floated.
That way the current traders will be stuffed, they seem to be the only ones asking for constant updates, they are also the ones that then start to pull apart any updates via interview, etc.

Lots of buys being going through in the sell column this morning

If POLB hadn't been spun out, it wouldn't have raised £25m and brought in these new assets, so what has happened with the spin off of POLB is a big positive.
Today's RNS is interesting, it looks to be adding more fat to the golden goose, making the CRO side of the business even more attractive to any buyers running a slide rule over
ORPH the Company.

https://www.newstalk.com/news/luke-oneill-explains-what-uk-scientists-learnt-from-deliberately-infecting-people-with-covid-19-1310119

https://bit.ly/363BUQK

ORPH, 2019 bumbling along in single figures, not really going anywhere, 2021 we see the SP 10 bag from 2 years previous.
Sometimes it is timing that makes the difference, not how much a share moves. No point in buying a ten bagger at near the top, better off buying something that is going to appreciate 50% at the bottom.

Hallsworthy not sure how POLB has contributed to decimating the ORPH SP?

Toastal,
TERN I was buying from 10p up to low teens and back down all the way to 2.1p, it was dire, but a bit of wind change and investment from Middle East saw it go from that 2p to a high of 57.1p which I managed to get 50k away at, shortly after a speeding ticket saw the price drop back into the mid 30p's.
It now sits back at 10-12p range.

A long time ago, I remember working for a Company in the City and each year as Christmas came around everyone eagerly awaited the news of the bonus, some years they were very good and then one year it wasn't great at all, we had no real warning and many of the other staff (had ordered new kitchens, paid for holidays on credit card, etc) all in anticipation of a good bonus. There is a moral here....

Try this...
https://t.co/C93qgYTx8i

Put '***************************' in the gap...

Goes some way to explain 'concerns' some have about speed of this study and capacity for future Covid studies

https://www.***************************/open-orphan-worlds-first-covid-19-characterisation-study-interview/4121049802

Government contracts for 4 Covid studies were for £40m (4x£10m), with 4x £2.5m of that non refundable deposits.
This is the results from the first study which was a characterisation study.